LianBio

NASDAQ: LIAN · Real-Time Price · USD
0.32
0.00 (0.31%)
At close: Jan 16, 2025, 10:00 PM

LianBio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-110.29M -196.3M
Depreciation & Amortization
1.01M 525K
Stock-Based Compensation
19.15M 8.66M
Other Working Capital
9.69M 15.49M
Other Non-Cash Items
-17.03M 9.31M
Deferred Income Tax
n/a 64K
Change in Working Capital
7.99M 13.79M
Operating Cash Flow
-99.19M -163.95M
Capital Expenditures
-1.84M -947K
Cash Acquisitions
n/a n/a
Purchase of Investments
-302.78M -154.99M
Sales Maturities Of Investments
235.5M n/a
Other Investing Acitivies
-80.03K -154.99K
Investing Cash Flow
-69.2M -155.94M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
1.71M -810K
Financial Cash Flow
1.71M 313.27M
Net Cash Flow
-168.89M -6.17M
Free Cash Flow
-101.03M -164.9M